Calyxt

Calyxt Current Liabilities

Delisted

The Current Liabilities of Calyxt (CLXT) as of Oct 11, 2026 is 2.41 M USD. In the previous year, Current Liabilities was 5.05 M USD — a change of -52.38% (lower).

Current Liabilities

2.41 MUSD

YoY

-52.38%

Last updated:

Current Liabilities of Calyxt is 2022 2.41 M USD. Current Liabilities of Calyxt was 2021 5.05 M USD. It decreases by -52.38% lower compared to the previous year.

The Calyxt Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2015
1.43 M USD
Jan 1, 2016
5.18 M USD
Jan 1, 2017
6.01 M USD
Jan 1, 2018
10.36 M USD
Jan 1, 2019
6.59 M USD
Jan 1, 2020
6.54 M USD
Jan 1, 2021
5.05 M USD
Jan 1, 2022
2.41 M USD
The Calyxt Current Liabilities history
YEARCurrent LiabilitiesYoY
2.41 MUSD-52.38%
5.05 MUSD-22.79%
6.54 MUSD-0.77%
6.59 MUSD-36.33%
10.36 MUSD+72.28%
6.01 MUSD+16.13%
5.18 MUSD+260.95%
1.43 MUSD—
Access this data via the Eulerpool API

Calyxt Stock analysis

What does Calyxt do? Calyxt Inc. is a US company specializing in the development and marketing of genetically modified plants. The company was founded in Minnesota in 2010 with the aim of producing high-quality, healthy, and environmentally friendly products that meet the requirements of modern and sustainable nutrition. History The history of Calyxt Inc. began with the idea of revolutionizing the cultivation of crops. The company was founded by Cellectis SA, which already had experience in the field of molecular biology. Calyxt developed technological processes for rapid genetic manipulation of plants that had the potential to change the entire agricultural industry. Business Model Calyxt follows an "end-to-end" business model, meaning the company offers products and services along the entire value chain. This ranges from the development of new plants through genetic modifications to the distribution and marketing of the end products. Divisions Calyxt specializes in the development of plant varieties optimized through genetic manipulation. The company has various divisions that focus on specific plant species, including: - Soybeans: Calyxt has developed a new variety of soybeans that contains a higher proportion of oleic acid, which improves the durability and quality of the beans. - Wheat: The company has also developed a variety of wheat that is low in gluten. This allows people with celiac disease or other reasons to avoid gluten to consume this variety. - Potatoes: Calyxt has developed a new variety of potatoes that contains less acrylamide than other varieties. Acrylamide is formed during the production of fries and chips and is suspected to cause cancer. Products Calyxt offers various products made from the plants they have developed, including: - Soybean oil: Calyxt soybean oil contains a higher proportion of healthy omega-3 fatty acids compared to conventional soybean oil. - Flour: Calyxt wheat flour is low in gluten and can be consumed by people with celiac disease or other reasons to avoid gluten. - Fries and chips: Calyxt potatoes contain less acrylamide than conventional potatoes, resulting in the formation of fewer harmful substances during the preparation of fries and chips. Conclusion Calyxt Inc. is an American company that develops genetically modified plants and connects them with customers, mainly in the food sector. The company aims to produce healthy, environmentally friendly, and high-quality products that meet the requirements of modern and sustainable nutrition. Various plant species are genetically modified to improve the durability and quality of the products while minimizing health risks. Calyxt Inc. offers various products made from the plants they have developed, with a focus on the production of fries and chips, as well as the distribution of soybean oil and low-gluten wheat flour. Calyxt has the potential to change modern agriculture through its innovative and sustainable products. Calyxt is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Calyxt stock

Current Liabilities of Calyxt is 2.41 M USD in 2022.

Current Liabilities of Calyxt changed from 5.05 M USD to 2.41 M USD, representing a -52.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Calyxt since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Calyxt historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Calyxt

All Key Metrics — Calyxt